Sorg Elaine K. 4
4 · AbbVie Inc. · Filed Apr 27, 2023
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Sorg Elaine K.
Sr. V.P., U.S. Commercial Ops.
Transactions
- Exercise/Conversion
Option (Right to Buy)
2023-04-25$144.54/sh−6,130$886,030→ 12,258 totalExercise: $144.54From: 2023-02-17Exp: 2032-02-16→ Common Stock (6,130 underlying) - Exercise/Conversion
Common Stock, $0.01 par value
2023-04-25$144.54/sh+6,130$886,030→ 41,460 total - Sale
Common Stock, $0.01 par value
2023-04-25$165.00/sh−6,130$1,011,450→ 35,330 total
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.00 to $165.03, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.